Brief: PhaseBio Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
18/03/2021 02:13
March 17 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON
STOCK
* PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 16,000,000
SHARES
OF COMMON STOCK AT PRICE OF $3.50 PER SHARE
Source text for Eikon: ID:nBw1DcPp7a
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans